TG4010 immunotherapy combined with first-line therapy in advanced non-small cell lung cancer (NSCLC): phase IIb results of the TIME study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Lecia V Sequist John Nemunaitis |
| Publication date | November 6, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |